Apomeds Launches Its Digital Healthcare Platform in the UK Market

The service aims to enhance access to care by offering a more tailored and convenient treatment experience for patients seeking private online healthcare, responding to growing demand for on demand medical services.

WEYBRIDGE, England , 11 Apr 2026 (Viralpressreleases.com) - Apomeds has introduced its digital healthcare platform in the United Kingdom, giving patients online access to registered doctors and regulated pharmacies. Patients complete a short medical questionnaire on the platform, which a doctor reviews. When clinically suitable, Apomeds issues a prescription that a registered pharmacy can deliver via a 24 hour tracked courier or to a patient’s chosen store. This creates an online healthcare marketplace that connects patients with licensed professionals through a digital first care model.
The UK launch is part of an expanding online marketplace that improves patient access to healthcare. Apomeds already operates in Germany, Switzerland, Sweden, Denmark, and Portugal, and is recognised as a well established online provider among patients. The UK market has actively supported the company’s global growth plans. One industry estimate projects the UK telehealth market to exceed $18.7 billion by 2035, driven by NHS digitisation and rising patient demand for alternative treatment methods.
One condition the platform addresses is erectile dysfunction, a large and well established patient market with high treatment demand. The NHS notes this condition is very common, especially in men over 40, highlighting the category’s scale in the UK. Through Apomeds, patients can have online consultations and, if suitable, receive commonly prescribed treatments like sildenafil and tadalafil while ensuring privacy and convenience.
Weight management is another strong growth sector. Demand for GLP-1 treatments such as Wegovy and Mounjaro has risen sharply, though UK access remains limited and often costly. NHS England’s staged rollout of tirzepatide explains why private and digital treatment pathways continue to attract interest. The UK prescription weight loss medication market is projected to grow from USD 421 million in 2025 to over USD 2.4 billion by 2033, expanding at a compound annual growth rate of nearly 25 percent.
The platform follows a straightforward care pathway: patients complete an online consultation, a doctor reviews the information, and if treatment is appropriate, issues a prescription. A partner pharmacy then dispenses the medication and delivers it to the patient’s home. This offers a flexible and discreet alternative to traditional routes, especially for those who value speed, convenience, and privacy. With exposure to two large treatment categories, Apomeds enters the UK as more patients embrace digital first care.

About Apomeds



Apomeds is a digital healthcare platform providing online access to licensed doctors and regulated pharmacies. It operates internationally across several European countries and is known for offering discreet, convenient treatment pathways. The company focuses on improving patient access through a digital first care model, serving categories such as erectile dysfunction and weight management. Its UK expansion strengthens its global footprint in a rapidly growing telehealth

Media Contacts


  • support@apomeds.com
  • Ibex House, 61 Baker Street, Weybridge, England

apomeds.com/uk

Category : Sports, Health, Medical, Beauty & Well-being

###

Disclaimer

Disclaimer

All the content in published press releases at Viral Press Releases is written and submitted by the press release author.

Viral Press Releases DO NOT accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in any published press release on viralpressreleases.com

If you have any question regarding some information in a press release, please contact the person listed in 'Media Contacts ' at the bottom of press release page.

Please DO NOT attempt to contact Viral Press Releases. We will be unable to assist you with any information regarding any published press release on Viral Press Releases.

Viral Press Releases disclaims any content contained in any published press release on Viral Press Releases.